News

  • TWSI Receives Funding for Prostate Cancer Surgical Product

    Date:2015-10-14    Source:Greenovo
    A previous Phase I award demonstrated feasibility of the chitosan endoluminal hemostatic dressing, its incorporation into a urinary catheter device, and its use to control bleeding in a large animal model The Phase II funding that has now been awarded provides for development of a final balloon-delivered hemostatic system
  • An Investigational RNAi Therapeutic for the Treatment of Hemophilia and Rare Bleeding Disorders

    Date:2015-10-13    Source:Greenovo
    Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi The company is leading the translation of RNAi as a new class of innovative medicines Alnylam s pipeline of investigational RNAi therapeutics is focused in 3 Strategic Therapeutic Areas (STArs)
  • New methods and products into trauma care and hemostatic

    Date:2015-10-12    Source:Greenovo
    Wuhan Greenovo biotechnology Co , LTD(Hereinafter referred to as “Greenovo”)was established at East lake high-tech development zone on February 14, 2012 It is a new type of biomedical materials research, development, production and marketing of high-tech enterprises
  • Hemostasis Global Clinical Trials Review

    Date:2015-10-10    Source:Greenovo
    The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) Global Data Clinical Trial Reports are generated using Global Data’s proprietary database – Pharma eTrack Clinical trials database Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe
  • Greenovo:Hemostasis products Market Expected to Reach USD 5.2 Billion globally in 2020

    Date:2015-10-10    Source:Greenovo
    According to a new market report published by Transparency Market Research “Hemostasis products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020” the global Hemostasis products Market was valued at USD 3 0 billion in 2013 and is estimated to reach a market worth of USD 5 2 billion in 2020 growing at a CAGR of 8 0% from 2014 to 2020
GREENOVO. China
EMAIL:sales@gnovo.cn
Address:B9-3, Hi-Tech
Medical Device Park
Wuhan 430206
China.
Tel: +86 27 87880126
Fax: +86 27 87880126